Download Free Sample Report

Opthalmology Drugs and Devices Market, Global Outlook and Forecast 2022-2028

Opthalmology Drugs and Devices Market, Global Outlook and Forecast 2022-2028

  • Published on : 12 July 2022
  • Pages :66
  • Report Code:SMR-7202925

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

Ophthalmology is a branch of medicine that deals with the anatomy, physiology, and diseases of the eye.
This report contains market size and forecasts of Opthalmology Drugs and Devices in Global, including the following market information:
Global Opthalmology Drugs and Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Opthalmology Drugs and Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Device Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Opthalmology Drugs and Devices include Merck (US), Pfizer (US), Roche Holdings (Switzerland), Santen Pharmaceutical(Japan), Alcon (Switzerland), Bausch & Lomb (US), Carl Zeiss Meditec (Germany), Essilor International S.A. (France) and Johnson & Johnson (US), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Opthalmology Drugs and Devices companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Opthalmology Drugs and Devices Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Opthalmology Drugs and Devices Market Segment Percentages, by Type, 2021 (%)
Device
Drug
Global Opthalmology Drugs and Devices Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Opthalmology Drugs and Devices Market Segment Percentages, by Application, 2021 (%)
Hosptial
Clinic
Others
Global Opthalmology Drugs and Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Opthalmology Drugs and Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Opthalmology Drugs and Devices revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Opthalmology Drugs and Devices revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck (US)
Pfizer (US)
Roche Holdings (Switzerland)
Santen Pharmaceutical(Japan)
Alcon (Switzerland)
Bausch & Lomb (US)
Carl Zeiss Meditec (Germany)
Essilor International S.A. (France)
Johnson & Johnson (US)
Nidek(Japan)
Topcon Corporation (Japan)